Chipscreen biosciences pipeline
WebApr 14, 2024 · Recently Concluded Data & Programmatic Insider Summit March 22 - 25, 2024, Scottsdale Digital OOH Insider Summit February 19 - 22, 2024, La Jolla WebFeb 27, 2024 · “Chipscreen Biosciences and Chipscreen NewWay have extensive experience in clinical drug development and commercialization,” said Dr. Yuelei Shen, President and CEO of Biocytogen. ... Biocytogen's pipeline includes 12 core products, among which two products are in phase II multi-regional clinical trials and two products …
Chipscreen biosciences pipeline
Did you know?
WebMar 23, 2024 · Dublin, March 23, 2024 (GLOBE NEWSWIRE) -- The "Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2024" report has been added to ... WebMost Recent Events. 18 Jan 2024 CS 12192 is still in preclinical trials for Graft-versus-host disease and Autoimmune disorders in China (Chipscreen Biosciences pipeline, January 2024) 18 Jan 2024 Phase-I clinical trials in Rheumatoid arthritis in China (PO) (Chipscreen Biosciences pipeline, January 2024) 18 Jan 2024 Preclinical trials in ...
WebAug 12, 2024 · Chipscreen Biosciences (688321.SH) is a clinical stage biotech company that is developing therapies for cancer and metabolic disorders. Among its late stage pipeline, CS055 is a histone deacetylase (HDAC) inhibitor, currently in Phase III clinical trials in China for non-Hodgkin's lymphoma (NHL). Headquarters Location WebFeb 18, 2024 · SHENZHEN, China, Feb. 17, 2024 /PRNewswire/ -- Chipscreen Biosciences, a leading integrated Chinese biotech company specialized in discovery and development of novel small molecule...
WebApr 16, 2024 · Shenzhen Chipscreen Biosciences Co., Ltd. (Chipscreen Biosciences, Stock Symbol: 688321.SH) was founded in Shenzhen in 2001, specializing in the research and development of novel small molecule drugs. WebChipscreen Biosciences focuses on cancer therapies. Chidamide ( Tusidinostat, Epidaza ® ), the first original innovative drug discovered and developed by Chipscreen, was the first oral subtype-selective histone …
WebChiauranib is an innovative, 3-pathway targeted kinase small molecule inhibitor with high selectivity against Auroa B /VEGFRs/CSF1R currently entering Phase III clinical trials in China. Lead Product (s): Chiauranib. Therapeutic Area: Oncology Product Name: CS2164. Highest Development Status: Phase III Product Type: Small molecule.
WebJun 24, 2024 · SHENZHEN, China, June 24, 2024 /PRNewswire/ -- Shenzhen Chipscreen Biosciences' licensing partner, HUYABIO International (HUYABIO™), today announced the regulatory approval for Tucidinostat... shulker box cyclerWebIn November 2024, Chidamide was approved by the NMPA in combination with an aromatase inhibitor for the treatment of post-menopausal patients with hormone receptor-positive, HER2-negative, recurrent or progressive locally advanced or metastatic breast cancer previously treated with endocrine therapy. shulk death battleWebApr 26, 2024 · Chipscreen Biosciences: Chiauranib/CS2164 : small-cell lung cancer : IND approved by the FDA : Illuminare Biotechnologies Memorial Sloan Kettering Cancer … shulker box crafting guide minecraftWebApr 11, 2024 · Request for a sample report to understand more about the Systemic Lupus Erythematosus pipeline development activities ... Gilead sciences, I-Mab Biopharma/MorphoSys AG, Chipscreen Biosciences, and ... shulker box craftenWebApr 16, 2024 · Shenzhen Chipscreen Biosciences Co., Ltd. (Chipscreen Biosciences, Stock Symbol: 688321.SH) was founded in Shenzhen in 2001, specializing in the … shulker box colors minecraftWebVice President, Global Head of Business Development & Sales and Marketing at Biocytogen Pharmaceuticals (Beijing) Co., Ltd ... shulker box craftingWebShenzhen Chipscreen Biosciences Co., Ltd., established in March 2001 by a group of senior scientists returned from the United States, is a pioneer in drug innovation and … shulker boxes plugin